NATHBIOGEN vs SANSTAR: Stock Comparison
SANSTAR is the larger company by market capitalisation. NATH BIO-GENES (I) shows a lower P/E, a higher ROE and faster revenue growth, while SANSTAR shows lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
NATHBIOGEN leads 9; SANSTAR leads 3 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Other Agricultural Products | Other Agricultural Products |
Price
| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| Live Price | ₹151.8 | ₹112.34 |
| Day Change | 3.03% | -2.9% |
| Volume | 1.1 L | 93,532 |
| 52-Week High | ₹204 | ₹137.49 |
| 52-Week Low | ₹126.15 | ₹74.3 |
| Distance from 52W High | -25.59% | -18.29% |
Valuation
| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| Market Cap | ₹285 Cr | ₹2,243 Cr |
| P/E Ratio | 8x | 47.26x |
| P/B Ratio | 0.43x | 2.94x |
| EPS | ₹17.18 | ₹0.46 |
| Book Value | ₹358.06 | ₹34.65 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| Revenue Growth (TTM YoY) | -1% | -14.5% |
| EPS Growth (TTM YoY) | 0% | 244.6% |
| Qtr Sales Growth | -1.69% | 0% |
| Qtr Profit Growth | 1.22% | 0% |
Profitability & Leverage
| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| ROE | 7.75% | 4.96% |
| ROCE | 5.81% | 5.17% |
| Net Margin | 9.35% | 5.5% |
| Operating Margin | 16.54% | 5.07% |
| Debt to Equity | 0.18x | 0.03x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | NATHBIOGEN | SANSTAR |
|---|---|---|
| Promoter Holding | 45.6% | 64.18%▼ 6.35 pp |
| FII Holding | 0.27%▲ 0.04 pp | 0.29%▲ 0.27 pp |
| DII Holding | 0.01% | 0.27%▼ 0.03 pp |
| Public Holding | 54.13%▼ 0.04 pp | 35.25%▲ 6.1 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NATH BIO-GENES (I) and SANSTAR.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.